NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use
January 27, 2020Sales and Marketing NHS, NICE, Novo Nordisk, UK, obesity, saxenda
NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda …
Chinese coronavirus spread is accelerating as Xi Jinping labels it a “grave situation”
January 27, 2020Sales and Marketing Chinese Coronavrius, MARS, Sars, Viral pnemonia, respiration
The spread of the Chinese coronavirus is accelerating, as multiple countries set up checks and tests to contain the virus. …
FDA greenlights its first therapy for advanced epithelioid sarcoma population
January 27, 2020Sales and Marketing Cancer, Epizyme, FDA, Tazverik, pharma
The FDA has revealed the approval of its first therapy for the treatment of metastatic or locally advanced epithelioid sarcoma, …
Judge overseeing Purdue Pharma bankruptcy approves $1.3 million bonus for CEO
January 27, 2020Sales and Marketing Election 2020, OxyContin, Purdue Pharma, US Presidential Race, fentanyl, opioid crisis
Purdue Pharma’s CEO Craig Landau can receive a $1.3 million bonus, ruled a judge. Judge Robert Drain said the company …
Top Ten most popular articles on Pharmafile.com this week
January 24, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Indian pharmaceutical firms received more than double the amount of warning letters in the first ten months of 2019, compared …
European Commission expands Stelara for paediatric moderate to severe plaque psoriasis
January 24, 2020Research and Development Europe, Janssen, Stelara, pharma
Janssen’s Stelara (ustekinumab) has seen its label expanded in Europe to include the treatment of moderate to severe plaque psoriasis …
FDA puts MDMA therapy for PTSD on its Expanded Access program
January 24, 2020Medical Communications Expanded Access, MAPS, MDMA, PTSD, pharmaceuticals, psychedelics, war
The FDA has made MDMA treatment for PTSD more accessible by putting it on the Expanded Access program. 10 sites …
Roche’s Tecentriq falls short as an adjuvant monotherapy in muscle-invasive urothelial cancer
January 24, 2020Medical Communications, Sales and Marketing Cancer, Roche, pharma, tecentriq, trial failure
Roche has released an update on the development of its immunology Tecentriq (atezolizumab), making it known that the drug failed …
UK tests 14 people for Chinese coronavirus
January 24, 2020Medical Communications Chinese Coronavirus, NHS, Public Health England, Viral outbreaks, Viral pnemonia, coronavirus, epidemic
14 people in the UK have been tested for the Chinese coronavirus, according to Public Health England (PHE). In Scotland, …
Former Insys sales exec sentenced to a year in prison for offering lap dances to encourage fentanyl spray prescriptions
January 23, 2020Medical Communications, Sales and Marketing insys, pharma
A sales executive at the disgraced and bankrupted firm Insys who was accused of offering lap dances in order to …
Oxford Immunotec to supply TB diagnostic tests to china to aid in coronavirus crisis
January 23, 2020Medical Communications, Sales and Marketing China, Oxford Immunotec Global, Wuhan, coronavirus, pharma
As fears rise over the impact and spread of Chinese coronavirus following news of a rising death toll and the …
NICE declines to recommend Astellas’ Xospata in rlapsed/refractory FLT3+ acute myeloid leukaemia
January 23, 2020Sales and Marketing Astellas, NHS, NICE, UK, Xospata, acute myeloid leukaemia
The latest in a series of rejections over the past week, NICE has revealed that it has knocked back the …
Roche’s risdiplam hits main goal in infants with spinal muscular atrophy
January 23, 2020Research and Development Roche, pharma, risdiplam, spinal muscular atrophy
Roche has announced the success of its survival motor neuron-2 (SMN2) splicing modifier risdiplam in a new trial investigating its …
China approves Roche cancer drug Kadcyla
January 22, 2020Business Services China, Roche, breast cancer, cancer treatment, oncology
China has approved the import of Roche’s drug for breast cancer, just after it recently won expanded approval in the …
FDA fast-tracks GSK’s multiple myeloma drug after priority review
January 22, 2020Research and Development BCMA, FDA, GSK, Phase 2 Trials, Phase Trials, multiple myeloma, myeloma
The FDA has fast tracked GlaxoSmithKline (GSK) antibody drug conjugate (ADC) belantamab mafodotin, for the treatment of patients with refractory …
Horizon’s Tepezza becomes first and only FDA-approved drug for thyroid eye disorder
January 22, 2020Research and Development FDA, Horizon Therapeutics, Tepezza, pharma
Horizon Therapeutics has announced that its IGF-1R inhibitor Tepezza (teprotumumab-trbw) has become the first and only therapy approved by the …
Chinese coronavirus set to be put on international health emergency list
January 22, 2020Research and Development Ebola, Public Health Emergency, WHO, World Health Organisation, Wuhan, polio, swine flu
The World Health Organisation (WHO) is expected to trigger a Public Health Emergency over the Wuhan coronavirus outbreak, meaning it …
No NICE recommendation for AstraZeneca’s Tagrisso in EGFR+ lung cancer
January 22, 2020Research and Development, Sales and Marketing AstraZeneca, NICE, Tagrisso, pharma
AstraZeneca’s Tagrisso (osimertinib) has been knocked back for routine use on the NHS in England and Wales by the drug …
Novartis establishes its new legal entity in Vietnam
January 22, 2020Research and Development Novartis, Novartis Vietnam, oncology, pharma
Novartis has inaugurated its new legal entity in Vietnam, Novartis Vietnam Co Ltd, and has become one of the first …
EU approval for Roche’s Polivy combo in relapsed/refractory B-cell lymphoma
January 21, 2020Manufacturing and Production, Sales and Marketing Cancer, Polivy, Roche, lymphoma, pharma
The European Commission has awarded conditional marketing approval to Roche’s Polivy (polatuzumab vedotin), it has been revealed.
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
